Status:
COMPLETED
Heart Rate Variability During the Menstrual Cycle
Lead Sponsor:
SPD Development Company Limited
Conditions:
Ovulation
Eligibility:
FEMALE
18+ years
Brief Summary
In this study, women will be required to wear a chest heart rate monitor and wrist heart rate monitor daily and collect daily early morning urine samples for the duration of one complete menstrual cyc...
Detailed Description
This study is a prospective observational study of women's heart rate and heart rate variability throughout one complete menstrual cycle. A minimum of 10 volunteers aged 18 years of age or over will b...
Eligibility Criteria
Inclusion
- Aged 18 years of age and over
- Regular menstrual cycles (23-35 days in length)-
Exclusion
- Taking any hormonal medications
- Taking any medications that may affect heart rate
- Known heart condition or use of a pacemaker
- Skin condition where there is sensitivity to wearing a skin monitor
- Currently suffering with anxiety or panic attacks
- Pregnant or breastfeeding
- Undertaking any frequent travel or long-haul flights during the course of the study
- Does not have access to an Apple iPhone or iPad with Bluetooth 4.0 (or later) and iOS 10.0 (or later)
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 6 2021
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04382001
Start Date
June 1 2020
End Date
May 6 2021
Last Update
August 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom, MK44 3UP